BE880970A - Composition pharmaceutique ayant une activite antitumorale - Google Patents
Composition pharmaceutique ayant une activite antitumorale Download PDFInfo
- Publication number
- BE880970A BE880970A BE6/47054A BE6047054A BE880970A BE 880970 A BE880970 A BE 880970A BE 6/47054 A BE6/47054 A BE 6/47054A BE 6047054 A BE6047054 A BE 6047054A BE 880970 A BE880970 A BE 880970A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- antibody
- tumor
- cells
- sarcoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16138878A JPS5592325A (en) | 1978-12-29 | 1978-12-29 | Antitumor agent and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE880970A true BE880970A (fr) | 1980-06-30 |
Family
ID=15734135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE6/47054A BE880970A (fr) | 1978-12-29 | 1979-12-28 | Composition pharmaceutique ayant une activite antitumorale |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS5592325A (2) |
| AU (1) | AU518952B2 (2) |
| BE (1) | BE880970A (2) |
| ZA (1) | ZA796896B (2) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5665828A (en) * | 1979-11-02 | 1981-06-03 | Kureha Chem Ind Co Ltd | Antitumor agent |
| JPS58118520A (ja) * | 1982-01-09 | 1983-07-14 | Hidematsu Hirai | 抗腫瘍性蛋白複合体およびその製造法 |
| US4448663A (en) * | 1982-07-06 | 1984-05-15 | The Dow Chemical Company | Double L-shaped electrode for brine electrolysis cell |
| JPH0651643B2 (ja) * | 1983-01-19 | 1994-07-06 | 帝人株式会社 | 殺細胞性修飾免疫グロブリン及びその製造方法 |
| JPH0611713B2 (ja) * | 1983-04-08 | 1994-02-16 | 呉羽化学工業株式会社 | ヒト免疫グロブリン結合抗腫瘍剤 |
| JPS6041617A (ja) * | 1983-08-18 | 1985-03-05 | Teijin Ltd | 殺細胞性修飾免疫グロブリン及びその製造法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS162953B1 (2) * | 1972-05-10 | 1975-07-31 | ||
| GB1509707A (en) * | 1974-09-20 | 1978-05-04 | Searle & Co | Immunological compounds |
| IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
-
1978
- 1978-12-29 JP JP16138878A patent/JPS5592325A/ja active Granted
-
1979
- 1979-12-19 ZA ZA00796896A patent/ZA796896B/xx unknown
- 1979-12-21 AU AU54144/79A patent/AU518952B2/en not_active Ceased
- 1979-12-28 BE BE6/47054A patent/BE880970A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5592325A (en) | 1980-07-12 |
| JPS6254086B2 (2) | 1987-11-13 |
| AU518952B2 (en) | 1981-10-29 |
| ZA796896B (en) | 1980-11-26 |
| AU5414479A (en) | 1980-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4315851A (en) | Pharmaceutical composition having antitumor activity | |
| FR2509313A1 (fr) | Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques | |
| FR2484258A1 (fr) | Agent immunotherapique pour tumeurs, avec du lipopolysaccharide comme composant actif, et procede de preparation de cet agent | |
| EP0037388B1 (fr) | Formes pharmaceutiques, leur préparation et les compositions qui les contiennent | |
| CH647531A5 (fr) | Derives alkyl-cetohexopyranosides. | |
| FR2490496A1 (fr) | Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant | |
| EP0751150B1 (fr) | Dérivés de cyclodextrines, leur préparation et leur utilisation pour incorporer des molecules hydrophobes dans des systèmes de tensioactifs organisés | |
| FR2522001A1 (fr) | Polysaccharides, leur preparation et compositions therapeutiques contenant ces produits | |
| BE880970A (fr) | Composition pharmaceutique ayant une activite antitumorale | |
| CA1248094A (fr) | Agent antitumoraux, tels que la daunorubicine a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux | |
| EP0255424B1 (fr) | Immunotoxines, procédé de préparation et compositions pharmaceutiques en contenant | |
| FR2709965A1 (fr) | Compositions pharmaceutiques ayant une activité antithrombotique et procédé pour leur préparation. | |
| BE882541A (fr) | Nouvelles formes pharmaceutiques leur preparation et les compositions qui les contiennent | |
| CH639395A5 (fr) | Glycoproteines constitutives d'hafnia, procede de preparation et compositions pharmaceutiques. | |
| FR2480122A1 (fr) | Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant | |
| EP0554445A1 (en) | Antineoplastic drug of plant extraction and process for the preparation thereof | |
| JP2514070B2 (ja) | 新規なグルコピラノ―ス誘導体 | |
| EP0571520B1 (fr) | Utilisation en therapeutique de pycnogenols pour la preparation de medicaments a activite anti-inflammatoire | |
| EP0162781A1 (fr) | Conjugués associant par liaison covalente un ionophore carboxylique monovalent et une macromolécule, leur utilisation comme agents potentialisateurs des immunotoxines et les ionophores activés intermédiaires | |
| JPS6256136B2 (2) | ||
| CH417852A (fr) | Procédé de préparation d'un antigène staphylococcique | |
| EP0126691B1 (fr) | Procédé de préparation d'un extrait de Brackenridgea zanguebarica utile en thérapeutique, extrait et médicament correspondant | |
| EP0283329A1 (fr) | Conjugués d'hydrazide d'alcaloide de vinca lie a une immunoglobuline | |
| EP0308279A1 (fr) | Nouveaux polysaccharides hydrosolubles, leur procédé d'obtention, leur application à titre de médicaments et préparation les renfermant | |
| CH633716A5 (en) | Method for separating and purifying products having interferon activity, purified preparations having interferon activity and use of the preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: KUREHA KAGAKU KOGYO K.K. Effective date: 19911231 |